National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Ramadan DJ, Kichula KM, Tao S, Porfilio T, Lande A, Fluge Ø, Mella O, Strand EB, Saugstad OD, Norman PJ, Lie BA, Viken MK(2025) Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Brain Behav Immun, 106098(in press) DOI 10.1016/j.bbi.2025.106098, PubMed 40897283
Beichmann B, Sollerud EP, Warmbrodt NS, Ottestad I, Paulsen MM, Henriksen C, Paur I(2025) Measured and predicted energy expenditure among patients with distal bowel cancer: Results from the GAIN-project Clin Nutr, 53, 88-98(in press) DOI 10.1016/j.clnu.2025.08.022, PubMed 40897149
Vandraas KF, Hjorth S, Trewin-Nybråten CB, Ursin G, Botteri E, Andreassen BK, Reinertsen KV, Blix ES, Naume B, Støer NC(2025) Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment Int J Cancer(in press) DOI 10.1002/ijc.70120, PubMed 40892038